Cogent Biosciences Inc

NASDAQ:COGT  
8.30
+0.10 (+1.22%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Cogent Biosciences Inc Stock, NASDAQ:COGT

200 Cambridge Park Drive, Suite 2500, Cambridge, Massachusetts 02140
United States of America
Phone: +1.617.945.5576
Number of Employees: 15

Description

Cogent Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Cambridge, MA.